IDT Biologika provides state-of-the art process development and GMP manufacturing facilities, with the capabilities to serve as a critical translational bridge from development through clinical to commercial BSL2 manufacturing. Our successful track record demonstrates that we can address significant challenges and fill vital development program needs of vaccine and biopharmaceutical customers. IDT has GMP compliant end-to-end equipment and operating capabilities that meet both FDA and EMA standards. We have many years of experience with live agents and proteins and the flexibility to support most platform technologies.